Qube Research & Technologies (QRT)
LMAT icon

Qube Research & Technologies (QRT)’s LeMaitre Vascular LMAT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Buy
154,879
+13,986
+10% +$1.43M 0.01% 1062
2026
Q1 		$15.4M Sell
140,893
-36,161
-20% -$3.45M 0.02% 1028
2025
Q4 		$14.4M Buy
177,054
+42,684
+32% +$3.67M 0.01% 1104
2025
Q3 		$11.8M Sell
134,370
-39,469
-23% -$3.52M 0.01% 1214
2025
Q2 		$14.4M Buy
173,839
+11,416
+7% +$954K 0.01% 1069
2025
Q1 		$13.6M Buy
162,423
+72,575
+81% +$6.75M 0.02% 946
2024
Q4 		$8.28M Buy
89,848
+31,498
+54% +$3.03M 0.01% 1210
2024
Q3 		$5.42M Buy
58,350
+48,769
+509% +$4.23M 0.01% 1350
2024
Q2 		$788K Sell
9,581
-17,394
-64% -$1.28M ﹤0.01% 1988
2024
Q1 		$1.79M Sell
26,975
-6,628
-20% -$409K ﹤0.01% 1825
2023
Q4 		$1.91M Buy
33,603
+22,850
+212% +$1.2M ﹤0.01% 1557
2023
Q3 		$586K Buy
10,753
+1,695
+19% +$100K ﹤0.01% 1958
2023
Q2 		$609K Buy
+9,058
New +$553K ﹤0.01% 1467
2022
Q1 		– Sell
-15,092
Closed -$758K – 2765
2021
Q4 		$758K Sell
15,092
-319
-2% -$16.5K 0.01% 1346
2021
Q3 		$818K Buy
+15,411
New +$868K 0.01% 978
2021
Q2 		– Sell
-10,071
Closed -$491K – 2572
2021
Q1 		$491K Buy
+10,071
New +$472K 0.01% 1191

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Qube Research & Technologies (QRT)'s LMAT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its LeMaitre Vascular (LMAT) stake by 9.9% in Q2 2026, buying an estimated $1.43M and bringing the position to 154,879 shares worth $14.9M. The position accounts for 0.01% of the portfolio, ranked #1062.

Qube Research & Technologies (QRT) first reported a position in LMAT in Q1 2021 and has held it in 16 quarters since. The position peaked at $15.4M in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Qube Research & Technologies (QRT) held 154,879 shares of LeMaitre Vascular worth $14.9M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 13,986 LeMaitre Vascular shares in Q2 2026, an estimated $1.43M.
  • LeMaitre Vascular made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1062 holding.
  • Qube Research & Technologies (QRT) first reported a position in LeMaitre Vascular in Q1 2021 and has held it in 16 quarters since.
  • Qube Research & Technologies (QRT)'s LeMaitre Vascular position peaked at $15.4M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.